Shire's oncology business (2018)
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:division
|
| gptkbp:acquiredBy |
gptkb:Servier
$2.4 billion |
| gptkbp:acquisitionYear |
2018
|
| https://www.w3.org/2000/01/rdf-schema#label |
Shire's oncology business (2018)
|
| gptkbp:industry |
oncology
|
| gptkbp:location |
gptkb:United_Kingdom
|
| gptkbp:notableProduct |
ONCASPAR
ONIVYDE |
| gptkbp:ownedBy |
gptkb:Shire_plc
|
| gptkbp:products |
oncology drugs
|
| gptkbp:bfsParent |
gptkb:Servier
|
| gptkbp:bfsLayer |
7
|